Abstract: The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
Type:
Application
Filed:
September 22, 2005
Publication date:
September 13, 2007
Applicant:
ProNAi Therapeutics, Southwest Michigan Innovation Center
Inventors:
Gholamreza Sheikhnejad, Neal Goodwin, David Olson